Anti-PM-Scl antibodies positive patients encompass three different groups with distinct prognosis.

Paul BreillatKuberaka MariampillaiPaul LegendrePauline MartinsBertrand DunogueJean Luc CharuelMakoto MiyaraClaire GoulvestreRomain PauleHelene VanquaethemFelix AckermannOlivier BenvenisteHilario NunesLuc MouthonYves AllenbachYurdagul Uzunhan

Published in: Rheumatology (Oxford, England) (2022)

Anti-PM-Scl-Abs associated auto-immune diseases are segregated into 3 subgroups with distinct clinical phenotype and outcomes. Skin thickening and NSIP are determinant predictors in segregation of theses populations.

Keyphrases

end stage renal disease
particulate matter
air pollution
newly diagnosed
ejection fraction
chronic kidney disease
heavy metals
prognostic factors
type diabetes
peritoneal dialysis
water soluble
weight loss
glycemic control